• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

时不变偏倚:评估术后放疗中经常被忽视的有效性威胁。

Immortal time bias: a frequently unrecognized threat to validity in the evaluation of postoperative radiotherapy.

机构信息

Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT, USA.

出版信息

Int J Radiat Oncol Biol Phys. 2012 Aug 1;83(5):1365-73. doi: 10.1016/j.ijrobp.2011.10.025. Epub 2012 Feb 16.

DOI:10.1016/j.ijrobp.2011.10.025
PMID:22342097
Abstract

PURPOSE

To evaluate the influence of immortal time bias on observational cohort studies of postoperative radiotherapy (PORT) and the effectiveness of sequential landmark analysis to account for this bias.

METHODS AND MATERIALS

First, we reviewed previous studies of the Surveillance, Epidemiology, and End Results (SEER) database to determine how frequently this bias was considered. Second, we used SEER to select three tumor types (glioblastoma multiforme, Stage IA-IVM0 gastric adenocarcinoma, and Stage II-III rectal carcinoma) for which prospective trials demonstrated an improvement in survival associated with PORT. For each tumor type, we calculated conditional survivals and adjusted hazard ratios of PORT vs. postoperative observation cohorts while restricting the sample at sequential monthly landmarks.

RESULTS

Sixty-two percent of previous SEER publications evaluating PORT failed to use a landmark analysis. As expected, delivery of PORT for all three tumor types was associated with improved survival, with the largest associated benefit favoring PORT when all patients were included regardless of survival. Preselecting a cohort with a longer minimum survival sequentially diminished the apparent benefit of PORT.

CONCLUSIONS

Although the majority of previous SEER articles do not correct for it, immortal time bias leads to altered estimates of PORT effectiveness, which are very sensitive to landmark selection. We suggest the routine use of sequential landmark analysis to account for this bias.

摘要

目的

评估观察性队列研究中永生时间偏倚对术后放疗(PORT)的影响,并评估序贯 landmark 分析对此偏倚的校正效果。

方法与材料

首先,我们回顾了 Surveillance、Epidemiology 和 End Results(SEER)数据库中的既往研究,以确定这种偏倚被考虑的频率。其次,我们使用 SEER 选择了三种肿瘤类型(多形性胶质母细胞瘤、IA-IVM0 期胃腺癌和 II-III 期直肠癌),前瞻性试验表明 PORT 与生存改善相关。对于每种肿瘤类型,我们计算了 PORT 与术后观察队列的条件生存率和调整后的危险比,同时在序贯每月 landmark 处限制样本。

结果

62%的评估 PORT 的既往 SEER 出版物未能使用 landmark 分析。正如预期的那样,对于所有三种肿瘤类型,PORT 的应用都与生存改善相关,当无论生存情况如何,所有患者均纳入时,PORT 相关的获益最大。预先选择一个具有更长最小生存时间的队列,会逐渐降低 PORT 的明显获益。

结论

尽管大多数既往 SEER 文章并未对此进行校正,但永生时间偏倚会导致 PORT 有效性的估计值发生改变,且这种改变对 landmark 的选择非常敏感。我们建议常规使用序贯 landmark 分析来校正这种偏倚。

相似文献

1
Immortal time bias: a frequently unrecognized threat to validity in the evaluation of postoperative radiotherapy.时不变偏倚:评估术后放疗中经常被忽视的有效性威胁。
Int J Radiat Oncol Biol Phys. 2012 Aug 1;83(5):1365-73. doi: 10.1016/j.ijrobp.2011.10.025. Epub 2012 Feb 16.
2
Stage-specific effect of adjuvant therapy following gastric cancer resection: a population-based analysis of 4,041 patients.胃癌切除术后辅助治疗的阶段特异性效应:基于4041例患者的人群分析
Ann Surg Oncol. 2008 Feb;15(2):500-7. doi: 10.1245/s10434-007-9640-0. Epub 2007 Nov 17.
3
Improved survival in patients with lymph node-positive gastric cancer who received preoperative radiation: an analysis of the Surveillance, Epidemiology, and End Results database.术前放疗可改善淋巴结阳性胃癌患者的生存:监测、流行病学和最终结果数据库分析。
Cancer. 2011 Sep 1;117(17):3908-16. doi: 10.1002/cncr.25995. Epub 2011 Mar 1.
4
Postoperative radiotherapy for stage II or III non-small-cell lung cancer using the surveillance, epidemiology, and end results database.利用监测、流行病学和最终结果数据库对II期或III期非小细胞肺癌进行术后放疗。
J Clin Oncol. 2006 Jul 1;24(19):2998-3006. doi: 10.1200/JCO.2005.04.6110. Epub 2006 Jun 12.
5
Adjuvant radiation therapy increases overall survival in node-positive gastric cancer patients with aggressive surgical resection and lymph node dissection: a SEER database analysis.辅助放疗可提高积极手术切除和淋巴结清扫的淋巴结阳性胃癌患者的总生存率:SEER 数据库分析。
Am J Clin Oncol. 2012 Jun;35(3):216-21. doi: 10.1097/COC.0b013e31820dbf08.
6
The survival impact of the intergroup 0116 trial on patients with gastric cancer.0116组间试验对胃癌患者的生存影响。
Int J Radiat Oncol Biol Phys. 2008 Oct 1;72(2):517-21. doi: 10.1016/j.ijrobp.2007.12.029. Epub 2008 Feb 4.
7
Improvement of survival with response to neoadjuvant radiation therapy for rectal cancer.直肠癌新辅助放疗反应改善生存率。
Arch Surg. 2009 Feb;144(2):129-34; discussion 134-5. doi: 10.1001/archsurg.2008.549.
8
Postoperative radiotherapy after surgical resection of thymoma: differing roles in localized and regional disease.胸腺瘤切除术后放疗:在局限性和区域性疾病中的不同作用。
Int J Radiat Oncol Biol Phys. 2010 Feb 1;76(2):440-5. doi: 10.1016/j.ijrobp.2009.02.016. Epub 2009 May 8.
9
Effectiveness of radiotherapy for elderly patients with glioblastoma.放疗治疗老年胶质母细胞瘤患者的效果。
Int J Radiat Oncol Biol Phys. 2011 Sep 1;81(1):206-10. doi: 10.1016/j.ijrobp.2010.04.033. Epub 2010 Aug 2.
10
An observational study suggesting clinical benefit for adjuvant postoperative chemoradiation in a population of over 500 cases after gastric resection with D2 nodal dissection for adenocarcinoma of the stomach.一项观察性研究表明,对于500多例因胃癌行D2淋巴结清扫胃切除术后的患者,辅助性术后放化疗具有临床益处。
Int J Radiat Oncol Biol Phys. 2005 Dec 1;63(5):1279-85. doi: 10.1016/j.ijrobp.2005.05.005. Epub 2005 Aug 15.

引用本文的文献

1
Comparison of metastasis and prognosis between early-onset and late-onset hepatocellular carcinoma: A population-based study.早发性与晚发性肝细胞癌转移及预后的比较:一项基于人群的研究。
Heliyon. 2024 Mar 26;10(7):e28497. doi: 10.1016/j.heliyon.2024.e28497. eCollection 2024 Apr 15.
2
Time interval between surgery and adjuvant chemotherapy in patients with gastric cancer after gastrectomy: a population-based cohort study using a nationwide claim database.胃癌胃切除术后患者手术与辅助化疗之间的时间间隔:一项基于全国索赔数据库的人群队列研究。
Ther Adv Med Oncol. 2024 Mar 29;16:17588359241241972. doi: 10.1177/17588359241241972. eCollection 2024.
3
Competing risks analysis of external versus internal radiation in patients with hepatocellular carcinoma after controlling for immortal time bias.
在控制不朽时间偏倚后,肝细胞癌患者接受外照射与内照射的竞争风险分析。
J Cancer Res Clin Oncol. 2023 Sep;149(12):9927-9935. doi: 10.1007/s00432-023-04915-8. Epub 2023 May 30.
4
Consolidative Radiotherapy for Metastatic Urothelial Bladder Cancer Patients with No Progression and with No More than Five Residual Metastatic Lesions Following First-Line Systemic Therapy: A Retrospective Analysis.一线全身治疗后无进展且残留转移病灶不超过五个的转移性尿路上皮膀胱癌患者的巩固性放疗:一项回顾性分析
Cancers (Basel). 2023 Feb 11;15(4):1161. doi: 10.3390/cancers15041161.
5
Immortal-time bias in older vs younger age groups: a simulation study with application to a population-based cohort of patients with colon cancer.老年与年轻年龄组之间的不朽时间偏倚:一项基于人群的结肠癌患者队列的模拟研究。
Br J Cancer. 2023 Apr;128(8):1521-1528. doi: 10.1038/s41416-023-02187-0. Epub 2023 Feb 9.
6
Impact of multi-agent systemic therapy on all-cause and disease-specific survival for people living with HIV who are diagnosed with non-Hodgkin lymphoma: population-based analyses from the state of Georgia.多模式系统治疗对诊断为非霍奇金淋巴瘤的 HIV 感染者全因和疾病特异性生存的影响:来自佐治亚州的基于人群的分析。
Leuk Lymphoma. 2023 Jan;64(1):151-160. doi: 10.1080/10428194.2022.2133539. Epub 2022 Oct 28.
7
Treatment paradigms and survival outcomes in esophageal adenocarcinoma with liver metastasis: a retrospective cohort study using the SEER database.食管腺癌伴肝转移的治疗模式与生存结局:一项使用监测、流行病学和最终结果(SEER)数据库的回顾性队列研究
J Gastrointest Oncol. 2022 Jun;13(3):935-948. doi: 10.21037/jgo-22-420.
8
Radiotherapy Plus Chemotherapy Leads to Prolonged Survival in Patients With Anaplastic Thyroid Cancer Compared With Radiotherapy Alone Regardless of Surgical Resection and Distant Metastasis: A Retrospective Population Study.放化疗联合治疗可显著延长未手术切除及远处转移的间变性甲状腺癌患者的生存期,优于单纯放疗:一项回顾性人群研究。
Front Endocrinol (Lausanne). 2021 Nov 1;12:748023. doi: 10.3389/fendo.2021.748023. eCollection 2021.
9
Injection Drug Use Endocarditis: An Inner-City Hospital Experience.注射吸毒所致心内膜炎:一家市中心医院的经验
CJC Open. 2021 Mar 9;3(7):896-903. doi: 10.1016/j.cjco.2021.02.015. eCollection 2021 Jul.
10
Describing Treatment Patterns for Elderly Patients with Intrahepatic Cholangiocarcinoma and Predicting Prognosis by a Validated Model: A Population-Based Study.描述肝内胆管癌老年患者的治疗模式并通过验证模型预测预后:一项基于人群的研究
J Cancer. 2021 Mar 30;12(11):3114-3125. doi: 10.7150/jca.53978. eCollection 2021.